Tempus AI Inc
Tempus AI Inc (TEM) Wheel Strategy
TEM wheel strategy scan found 166 cash-secured put setups on the previous trading day. Probability of expiring worthless is above 50%. Annualized returns reach up to 396.7%.
Read more
Running a TEM wheel strategy lets you generate consistent premium income on Tempus AI Inc while setting your own entry and exit prices on the underlying. Tempus AI Inc's wheel combines cash-secured puts and covered calls into a repeatable cycle: sell puts at strikes where you'd be happy to own TEM, and if assigned, sell calls at strikes where you'd be happy to sell. Use our scanner to find the best TEM wheel strategy setups in real time.
The wheel works best on liquid, high-quality names with stable fundamentals and active options markets — exactly the profile many large-cap leaders fit. The mechanics are simple: sell a cash-secured put on TEM, collect premium, and either keep the premium if it expires worthless or take assignment at a discount to current price. Once assigned, sell covered calls against the shares to keep collecting premium until they're called away. Choosing the right strikes, expirations, and IV environment is what separates a profitable TEM wheel from a losing one.
Tempus AI, Inc. operates as a healthcare technology company. It engages in providing next generation sequencing diagnostics, polymerase chain reaction profiling, molecular genotyping, and other anatomic and molecular pathology testing to healthcare providers, pharmaceutical companies, biotechnology companies, researchers, and other third parties. The company offers Insights, a license library of linked clinical, molecular, and imaging de-identified data, as well as a suite of analytical services to analytic and cloud-and-compute tools to pharmaceutical and biotechnology companies; and Trials that provides clinical trial matching services to pharmaceutical companies.
In addition, it operates Next; Algos, a suite of algorithmic tests in oncology; Hub, a desktop and mobile platform for ordering, managing, and receiving tests and patient results; and Lens, a platform for researchers and scientists to find, access, and analyze Tempus data. The company has a strategic collaborations agreement with AstraZeneca and Pathos AI, Inc. to develop therapeutic programs in oncology. The company was formerly known as Tempus Labs, Inc. and changed its name to Tempus AI, Inc. in January 2023. Tempus AI, Inc. was incorporated in 2015 and is headquartered in Chicago, Illinois.
The difference between a wheel that compounds and one that bleeds comes down to strike selection, IV timing, and discipline on assignment. Our scanner handles the heavy lifting: it ranks every leg of the TEM wheel strategy by delta, premium yield, IV rank, and days to expiration, so you can deploy capital where the math works. Build your TEM wheel strategy on data, not gut feel — and let the options wheel do what it does best: pay you to wait.
| Sep 18, 2026 | 69.00 | $1.30 | $1.50 | -0.41 | 2 | 60% | 59.5% | 396.7% | 196 |
| Sep 18, 2026 | 68.00 | $0.98 | $1.05 | -0.32 | 2 | 60% | 69.7% | 281.8% | 95 |
| Sep 18, 2026 | 67.00 | $0.69 | $0.75 | -0.25 | 2 | 60% | 78.6% | 204.3% | 121 |
| Sep 18, 2026 | 66.00 | $0.47 | $0.71 | -0.22 | 2 | 60% | 85.9% | 196.3% | 216 |
| Sep 25, 2026 | 69.00 | $2.70 | $3.15 | -0.43 | 9 | 60% | 52.6% | 185.1% | 12 |
| Sep 25, 2026 | 68.00 | $2.28 | $2.77 | -0.39 | 9 | 60% | 57.4% | 164.9% | 44 |
| Oct 2, 2026 | 69.00 | $2.93 | $4.09 | -0.43 | 16 | 60% | 50.7% | 135.2% | 3 |
| Oct 2, 2026 | 68.00 | $3.00 | $3.88 | -0.40 | 16 | 60% | 54.3% | 130.0% | 5 |
| Sep 25, 2026 | 67.00 | $1.82 | $2.03 | -0.34 | 9 | 60% | 62.2% | 122.9% | 24 |
| Sep 25, 2026 | 66.00 | $1.50 | $1.80 | -0.30 | 9 | 60% | 66.9% | 110.6% | 37 |
As of September 17, 2026
Run the Wheel on TEM With Confidence
Find the best TEM wheel strategy setups across strikes and expirations, plan ahead with at-strike values, and keep your covered calls and puts on track.
Start your 14-day free trial→